Skip to main content

Dermorphin

No sources yet

An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.

Source summary generated November 6, 2026; this date does not indicate completed review.

Tissue researchAliases: dermorphine
Track your own protocol free →

Quotes from three independent practitioners, with their sources. Research context only.

What it is and how it works

From the published literature on Dermorphin; the papers are listed at the end. Research summary, not a recommendation.

What it is

Dermorphin is a seven-amino-acid peptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) first isolated from the skin of frogs of the Phyllomedusinae group, reported in 1980 as the first of a family of natural opioid peptides. Its second amino acid is the unusual D-form of alanine, which is rare in animal proteins and helps it resist breakdown. It is a natural opioid, and the published literature is a mix of pharmacology reviews, rodent work and a horse study.

How it works

Dermorphin binds mu-opioid receptors (the receptors that morphine and other opioid painkillers act on) with very high selectivity. In rodents it was a far more potent pain-blocker than morphine, and reviews report that some family members cross the blood-brain barrier after injection outside the brain. The N-terminal four amino acids were found to be the minimum sequence needed for activity, and swapping the D-alanine for D-arginine produced analogues that resisted enzymatic breakdown and were studied as longer-lasting analgesics.

What it has been studied for

  • Pain relief (antinociception) in rodents and primates (reviews)
  • Stable tetrapeptide analogues as morphine alternatives (review)
  • Frostbite-related pain in rats, using a dermorphin analogue that acts on peripheral opioid receptors
  • Dose-response and clearance in horses, after detection in race samples

Strength of the evidence

Animal and lab studiesThe literature found consists of reviews, rodent and primate pharmacology and a horse study; no controlled human trial of dermorphin itself was identified.

What the literature reports on safety

As a mu-opioid agonist, dermorphin shares the class risks that the literature lists for opioids, including sedation, respiratory depression and dependence. No dermorphin medicine approved by the FDA was identified in the sources checked, and it is not named on the FDA compounding-substances page (content current as of 2026-04-22). A 2015 veterinary paper notes dermorphin has been identified in post-race horse samples, and a World Athletics summary of the 2026 prohibited list shows dermorphin and analogues among the in-competition narcotics; check the current official list.

Key papers

  1. The dermorphin peptide family. (opens in a new tab)

    Review · Melchiorri P, Negri L · General Pharmacology (1996) · PMID 8981054

    Described the frog-skin dermorphin peptides as selective mu-opioid agonists, potent analgesics in rodents and primates, and a family of seven natural peptides and nearly 30 synthetic analogues.

  2. Pharmacology of amphibian opiate peptides. (opens in a new tab)

    Review · Negri L, Melchiorri P, et al. · Peptides (2000) · PMID 11090917

    Reviewed dermorphins and the later-found delta-opioid deltorphins, noting their D-amino acid in the second position and their value as models for analgesics with reduced toxicity.

  3. Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine. (opens in a new tab)

    Review · Mizoguchi H, Bagetta G, et al. · Peptides (2011) · PMID 21126548

    Found that the first four amino acids are the minimum for mu-opioid activity and that D-arginine analogues resisted breakdown and out-performed morphine in animal pain tests.

  4. Dermorphin [D-Arg2, Lys4] (1-4) Amide Alleviates Frostbite-Induced Pain by Regulating TRP Channel-Mediated Microglial Activation and Neuroinflammation. (opens in a new tab)

    Animal study · Ummadisetty O, Akhilesh, et al. · Molecular Neurobiology (2024) · PMID 38277118

    In rats with frostbite injury, a dermorphin analogue acting on peripheral mu-opioid receptors reduced pain hypersensitivity and neuroinflammation.

  5. Pharmacokinetics and pharmacodynamics of dermorphin in the horse. (opens in a new tab)

    Animal study · Robinson MA, Guan F, et al. · Journal of Veterinary Pharmacology and Therapeutics (2015) · PMID 25376170

    Measured how quickly dermorphin was cleared from horse plasma (elimination half-life under one hour) after it was identified in post-race samples.

Sources checked: PubMed (E-utilities abstracts for every PMID), FDA compounding-substances page (current as of 2026-04-22), World Athletics summary of the 2026 Prohibited List (via search, unverified against the official WADA text), written 2026-11-06.

No sources yet

None of the three teachers' sources we have indexed discuss Dermorphin yet. This page will fill in as sources are added.

Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.

Disclaimer: for research purposes only

All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.

Dermorphin — Hunter, Taylor, Bachmeyer | Reset Biology